Chuck Royce Sells 31,364 Shares of Apyx Medical Corp

Charles Royce's firm reduced Apyx Medical Corp holdings by 31,364 shares at $3.50 per share, but still holds 2,443,035 shares, representing 0.09% of the portfolio. Apyx is a medical device company with a market capitalization of $162.887 million and a current stock price of $3.97, considered overvalued according to GF Valuation. The stock has experienced a 13.43% gain since the transaction and an 86.82% increase since its IPO, but faces financial challenges with a negative return on equity and return on assets.